Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Coal tar 40% bath emulsion
1305020C0AAABAB
|
Coal tar/tar (Topical) | Tars | Skin | 158 |
|
Warticon 0.15% cream
1307000K0BBACAB
|
Warticon | Podophyllotoxin | Skin | 154 |
|
Curanail 5% medicated nail lacquer
1310020A0BCAAAA
|
Curanail | Amorolfine hydrochloride | Skin | 149 |
|
Nerisone Forte 0.3% oily cream
1304000L0BBACAC
|
Nerisone | Diflucortolone valerate | Skin | 147 |
|
Curatoderm 4micrograms/g lotion
1305020R0BBABAB
|
Curatoderm | Tacalcitol | Skin | 146 |
|
Roaccutane 10mg capsules
1306020J0BBACAC
|
Roaccutane | Isotretinoin | Skin | 141 |
|
Psoriderm Emulsion 40% bath additive
1305020C0BDAAAB
|
Psoriderm (Topical) | Tars | Skin | 140 |
|
Betadine 2.5% dry powder spray
1311040K0BCAAAB
|
Betadine (Topical cleanser) | Iodine compounds | Skin | 139 |
|
Lyclear 1% creme rinse
1310040Q0BBAAAA
|
Lyclear | Permethrin | Skin | 138 |
|
Acea 0.75% gel
1310012K0BJAAAR
|
Acea | Metronidazole | Skin | 137 |
|
Fluocinolone acetonide 0.025% / Clioquinol 3% ointment
1304000N0AACCCC
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 137 |
|
Anthelios XL cream SPF 50+
130801000BBNWA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 136 |
|
Isotretinoin 5mg capsules
1306020J0AAAAAA
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 136 |
|
Beclometasone 0.025% ointment
1304000C0AABABA
|
Beclometasone dipropionate (Topical) | Beclometasone dipropionate | Skin | 135 |
|
Povidone-Iodine 2.5% dry powder spray
1311040K0AAABAB
|
Povidone-Iodine (Topical Disinfectant/Cleanser) | Iodine compounds | Skin | 134 |
|
Zovirax Cold Sore 5% cream
1310030C0BBABAA
|
Zovirax (Topical) | Aciclovir | Skin | 132 |
|
Eucerin UreaRepair Plus 10% urea foot cream
1302010U0BGAIAF
|
Eucerin | Urea | Skin | 128 |
|
Povidone-Iodine 7.5% surgical scrub solution
1311040K0AAAKAK
|
Povidone-Iodine (Topical Disinfectant/Cleanser) | Iodine compounds | Skin | 126 |
|
Canesten Dermatological 1% spray
1310020H0BBACAE
|
Canesten (Topical) | Clotrimazole | Skin | 121 |
|
Silver nitrate 95% caustic applicators
1307000Q0AAAEAE
|
Silver nitrate | Silver nitrate | Skin | 121 |
|
Mycota powder
1310020Z0BCABAE
|
Mycota | Undecenoates | Skin | 119 |
|
Canesten Antifungal cream
1310020H0BBAHAB
|
Canesten (Topical) | Clotrimazole | Skin | 118 |
|
MooGoo Skin Milk Udder cream
131500000BBNFA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 118 |
|
Chlorhexidine gluconate 0.05% solution 25ml sachets
1311020L0AAAGAG
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 115 |
|
Germolene antiseptic cream
1310050P0BBABAD
|
Germolene (Phenol) | Phenol | Skin | 115 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.